• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Utilities·688101.SS
Share

Suntar Environmental Technology Co., Ltd. Stocks

CN¥ 16.16Last Updated 26.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 838.35M

CN¥ 16.16
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Suntar Environmental Technology Co., Ltd., established in 2005 and headquartered in Xiamen, China, specializes in delivering advanced industrial membrane separation solutions across the nation. The company's extensive service portfolio includes ceramic, spiral, and PP/PE membrane separation techniques, alongside sophisticated offerings such as flow-cel membrane technology, solvent recovery systems, membrane bioreactor (MBR) applications, continuous chromatography separation, and ion exchange processes. Additionally, Suntar manufactures and supplies a variety of specialized products, including ceramic, spiral wound, hollow fiber, and spiral membranes, as well as laboratory equipment and Integrated Membrane Bioreactors (IMBRs). Their tailored solutions cater to a diverse clientele within the biological, chemical engineering, pharmaceutical, and food and beverage sectors.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.06.2026 21:00

OpenAI's New Plans, European Tanks, and a Mega-Deal in China: The Lowdown on IPOs as of June 28

28.06.2026 15:01

Collective Sentiment: How Much Influence Do Financial Influencers Have?

28.06.2026 11:41

The U.S. and Iran continued to exchange blows despite the agreement

27.06.2026 16:01

Small caps last week: Hertz's dark day, Wendy’s meme rally, OpenAI IPO beneficiaries

27.06.2026 13:01

Fantastic mega-adventures, magical healings, and amazing transformations

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026